https://www.selleckchem.com/pr....oducts/Sapogenins-gl
Sexual dysfunction (SD) is experienced by 50% of stroke survivors, and it is identified as critical in their rehabilitation management, but often remains unaddressed. To evaluate the effectiveness and adverse events of currently available interventions for SD following stroke. A summary of the Cochrane Review by Stratton et al. 2020, with comments from a rehabilitation perspective. Three randomized control trials with a total of 212 participants were included. Evidence quality was very low for all assessed interventions (p
Like
Comment
Share
